Abstract: A method of manufacturing an electrode structure for a device, such as a GaN or AlGaN device is described. In one example, the method includes providing a substrate (212) of GaN or AlGaN with a surface region of the GaN or AlGaN exposed through an opening (216) in a layer of silicon nitride (214) formed on the substrate. The method further includes depositing layers of W (222), in one example, or Ni (220) and W (222), in another example, on the substrate and the layer of silicon nitride using reactive evaporation and photoresist layers (230) having an undercut profile for liftoff. The method further includes removing the photoresist layers having the undercut profile, and depositing layers of WN (224) and Al over the underlying layers of W or Ni and W by sputtering.

Abstract: Various embodiments are disclosed for improved and structurally optimized transistors, such as RF power amplifier transistors. A transistor may include a drain metal portion raised from a surface of a substrate, a drain metal having a notched region, a gate manifold body with angled gate tabs extending from the gate manifold, and/or a source-connected shielding. The transistor may include a high-electron-mobility transistor (HEMT), a gallium nitride (GaN)-on-silicon transistor, a GaN-on-silicon-carbide transistor, or other type of transistor.

Abstract: A pulley is disclosed, that comprises: a block formed from first and second spaced-apart plates; a sheave axle that interconnects and is secured to the plates; a sheave carried for rotation on the sheave axle between the plates; and a becket assembly comprising a becket axle that interconnects and is removably secured to the plates and a blocking component carried on the becket axle. The becket axle can be removed from the pulley to enable removal of the blocking component from the pulley. This allows a rope or similar element to be introduced between or removed from between the plates.

Abstract: Methods and compositions to genotype microspores and/or pollen grains are provided. Methods provided include using meiotically-related products to non-destructively determine the genotype of one of the meiotically-related products such that it can be further used. For example, methods to obtain a genotype of a microspore are provided. The methods include: isolating tetrads, separating the tetrads to obtain four tetrad microspores; genotyping three of the four tetrad microspores, and inferring the genotype of the fourth tetrad microspore. Methods are also provided for generating doubled haploid plants from the microspores that are selected for further analysis based on inferred genotypes. Viable genotyped pollen produced by these methods, as well as seed, cells, plants, germplasm, progeny, and plant parts derived therefrom are also provided.

Abstract: A plastic keg includes a liner including a neck portion and a body portion. A lid having an opening is disposed at least partially over the liner. A retainer is secured to the neck portion of the liner and aligned with the opening in the lid, the retainer including external threads. A locking ring having internal threads is secured to the external threads of the retainer. The internal threads of the locking ring and the external threads of the retainer include a ratcheting mechanism permitting attachment of the locking ring to the retainer and inhibiting removal of the locking ring from the retainer, the locking ring contacting the lid. A beer keg valve assembly includes a port having a head portion having a convex upper surface and at least one leg extending downwardly from a lower surface. The leg includes a stop surface projecting radially outward further than the head portion. A piston defines an opening.

Abstract: Methods and compositions to genotype microspores and/or pollen grains are provided. Methods provided include using meiotically-related products to non-destructively determine the genotype of one of the meiotically-related products such that it can be further used. For example, methods to obtain a genotype of a microspore are provided. The methods include: isolating tetrads, separating the tetrads to obtain four tetrad microspores; genotyping three of the four tetrad microspores, and inferring the genotype of the fourth tetrad microspore. Methods are also provided for generating doubled haploid plants from the microspores that are selected for further analysis based on inferred genotypes. Viable genotyped pollen produced by these methods, as well as seed, cells, plants, germplasm, progeny, and plant parts derived therefrom are also provided.

Abstract: A plastic keg includes a liner including a neck portion and a body portion. A lid having an opening is disposed at least partially over the liner. A retainer is secured to the neck portion of the liner and aligned with the opening in the lid, the retainer including external threads. A locking ring having internal threads is secured to the external threads of the retainer. The internal threads of the locking ring and the external threads of the retainer include a ratcheting mechanism permitting attachment of the locking ring to the retainer and inhibiting removal of the locking ring from the retainer, the locking ring contacting the lid. A beer keg valve assembly includes a port having a head portion having a convex upper surface and at least one leg extending downwardly from a lower surface. The leg includes a stop surface projecting radially outward further than the head portion. A piston defines an opening.

Abstract: A plastic keg includes a liner including a neck portion and a body portion. A lid having an opening is disposed at least partially over the liner. A retainer is secured to the neck portion of the liner and aligned with the opening in the lid, the retainer including external threads. A locking ring having internal threads is secured to the external threads of the retainer. The internal threads of the locking ring and the external threads of the retainer include a ratcheting mechanism permitting attachment of the locking ring to the retainer and inhibiting removal of the locking ring from the retainer. A beer keg valve assembly includes a port having a head portion having a convex upper surface and at least one leg extending downwardly from a lower surface. The leg includes a stop surface projecting radially outward further than the head portion.

Abstract: The present invention is directed to pharmaceutically acceptable polymeric compositions suitable for injection molding of single or multi-component pharmaceutical dosage forms comprising a plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form by a weld between parts of the assembled dosage form.

Abstract: A plastic keg includes a liner including a neck portion and a body portion. A lid having an opening is disposed at least partially over the liner. A retainer is secured to the neck portion of the liner and aligned with the opening in the lid, the retainer including external threads. A locking ring having internal threads is secured to the external threads of the retainer. The internal threads of the locking ring and the external threads of the retainer include a ratcheting mechanism permitting attachment of the locking ring to the retainer and inhibiting removal of the locking ring from the retainer, the locking ring contacting the lid. A beer keg valve assembly includes a port having a head portion having a convex upper surface and at least one leg extending downwardly from a lower surface. The leg includes a stop surface projecting radially outward further than the head portion. A piston defines an opening.

Abstract: The present invention is directed to pharmaceutically acceptable polymeric compositions suitable for injection molding of single or multi-component pharmaceutical dosage forms comprising a plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form by a weld between parts of the assembled dosage form.

Abstract: The present invention is directed to pharmaceutically acceptable polymeric compositions suitable for injection molding of single or multi-component pharmaceutical dosage forms comprising a plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form by a weld between parts of the assembled dosage form.

Abstract: The invention provides a flooring system for covering a surface, the system comprising a first portion and a second portion, the first portion being substantially rectangular in cross section and comprising a gripping material, wherein at least one channel is provided in the flooring system and the first portion is located in said channel.

Abstract: The present invention is directed to novel pharmaceutically acceptable polymeric compositions suitable for melt extrusion and injection molding of single or multi-component pharmaceutical dosage forms comprising a plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form.

Abstract: A multi-component pharmaceutical dosage form suitable for retaining drug substance can be released to provide a controlled drug release profile in the gastro intestinal environment, characterized by a body e.g. comprising a delayed release polymeric material such as Eudragit 4135F, the body having at least one cavity said cavity having a mouth opening and a film means e.g. comprising an immediate release polymeric material e.g. Eudragit E100 or a blend thereof, connected to the body and closing the mouth opening.

Abstract: The present invention is directed to novel pharmaceutically acceptable polymeric compositions suitable for melt extrusion and injection molding of single or multi-component pharmaceutical dosage forms comprising a plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form.

Abstract: The present invention is directed to pharmaceutically acceptable polymeric compositions suitable for injection molding of single or multi-component pharmaceutical dosage forms comprising a plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form by a weld between parts of the assembled dosage form.

Abstract: The present invention is directed to pharmaceutically acceptable polymeric compositions suitable for injection molding of single or multi-component pharmaceutical dosage forms comprising a plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form by a weld between parts of the assembled dosage form.